Back to search

Article

House dust mite SCIT reduces asthma risk and significantly improves long-term rhinitis and asthma control -- a RWE study

2023-05-08

Abstract excerpt

<h4>Background: </h4> The German Therapy Allergen Ordinance (TAO) triggered an ongoing upheaval in the market for house dust mite (HDM) allergen immunotherapy (AIT) products. Three HDM subcutaneous AIT (SCIT) products hold approval in Germany and therefore will be available after the scheduled completion of the TAO procedure in 2026. In general, data from clinical trials on the long-term effectiveness of HDM AIT a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7a78b2a8-c0be-5117-8b7a-d966e1f09c27
DOI
10.22541/au.168351492.25008933/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
House dust mite SCIT reduces asthma risk and significantly improves long-term rhinitis and asthma control -- a RWE studyDOI 10.22541/au.168351492.25008933/v1
Select a neighboring publication to make it the new centre.